Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Case-control study of salmeterol and near-fatal attacks of asthma.

Williams C, Crossland L, Finnerty J, Crane J, Holgate S, Pearce N, Beasley R.

Thorax. 1998 Jan;53(1):7-13.

2.

Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews.

Cates CJ, Wieland LS, Oleszczuk M, Kew KM.

Cochrane Database Syst Rev. 2014 Feb 6;(2):CD010314. doi: 10.1002/14651858.CD010314.pub2. Review.

PMID:
24504983
3.

Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.

Cates CJ, Lasserson TJ, Jaeschke R.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD006922. doi: 10.1002/14651858.CD006922.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;3:CD006922.

PMID:
19588410
4.

Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.

Cates CJ, Jaeschke R, Schmidt S, Ferrer M.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD006922. doi: 10.1002/14651858.CD006922.pub3. Review.

PMID:
23543548
5.

Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children.

Chauhan BF, Chartrand C, Ni Chroinin M, Milan SJ, Ducharme FM.

Cochrane Database Syst Rev. 2015 Nov 24;(11):CD007949. doi: 10.1002/14651858.CD007949.pub2. Review.

PMID:
26594816
6.

Adverse effects of beta-agonists: are they clinically relevant?

Abramson MJ, Walters J, Walters EH.

Am J Respir Med. 2003;2(4):287-97. Review.

PMID:
14719995
7.

Salmeterol: a novel, long-acting beta 2-agonist.

Meyer JM, Wenzel CL, Kradjan WA.

Ann Pharmacother. 1993 Dec;27(12):1478-87. Review.

PMID:
7905757
8.

Long-acting beta2-agonists versus theophylline for maintenance treatment of asthma.

Tee AK, Koh MS, Gibson PG, Lasserson TJ, Wilson AJ, Irving LB.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD001281. Review.

PMID:
17636663
9.

Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review.

Rodrigo GJ, Moral VP, Marcos LG, Castro-Rodriguez JA.

Pulm Pharmacol Ther. 2009 Feb;22(1):9-19. doi: 10.1016/j.pupt.2008.10.008. Epub 2008 Nov 5. Review.

PMID:
19026757
10.
11.

Long acting beta-agonists versus theophylline for maintenance treatment of asthma.

Shah L, Wilson AJ, Gibson PG, Coughlan J.

Cochrane Database Syst Rev. 2003;(3):CD001281. Review. Update in: Cochrane Database Syst Rev. 2007;(3):CD001281.

PMID:
12917905
12.

Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events.

Cates CJ, Lasserson TJ.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD007695. doi: 10.1002/14651858.CD007695.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;3:CD007695.

PMID:
19821436
13.

Salmeterol: a long-acting beta 2-agonist.

D'Alonzo GE, Tolep K.

J Am Osteopath Assoc. 1998 Apr;98(4):216-8, 221-31. Review.

PMID:
9594486
14.

Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children.

Lasserson TJ, Ferrara G, Casali L.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD004106. doi: 10.1002/14651858.CD004106.pub4. Review.

PMID:
22161385
15.

Long-acting beta-agonists role in asthma management.

Donohue JF, Fromer L.

J Fam Pract. 2006 Apr;Suppl:1-6. Review.

PMID:
16715643
16.

Long acting beta-agonists versus theophylline for maintenance treatment of asthma.

Wilson AJ, Gibson PG, Coughlan J.

Cochrane Database Syst Rev. 2000;(2):CD001281. Review. Update in: Cochrane Database Syst Rev. 2003;(3):CD001281.

PMID:
10796631
17.
18.

Supplemental Content

Support Center